Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 disease

Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 disease

Lung Cancer is still one of the leading causes for cancer related death worldwide. The determination of an adequate therapeutic approach requests a precise staging, which contains computed tomography (CT) of the thorax, positron emission tomography computed tomography (PET-CT), cerebral magnetic res...

Full description

Bibliographic Details
Main Authors: Hruy Menghesha, Fabian Doerr, Georg Schlachtenberger, Andres Amorin Estremadoyro, Karin Töpelt, Thorsten Wahlers, Khosro Hekmat, Matthias Heldwein
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Non-small cell lung cancer
Neoadjuvant
Immunotherapy
Surgical therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007122001502

Internet

http://www.sciencedirect.com/science/article/pii/S2213007122001502

Similar Items